Old Web
English
Sign In
Acemap
>
authorDetail
>
L. M. Mittlmeier
L. M. Mittlmeier
Ludwig Maximilian University of Munich
Medicine
PET-CT
Renal cell carcinoma
Pathology
Tyrosine-kinase inhibitor
3
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma
2020
European Journal of Nuclear Medicine and Molecular Imaging
L. M. Mittlmeier
Marcus Unterrainer
Andrei Todica
Clemens C. Cyran
Severin Rodler
Peter Bartenstein
C.G. Stief
Harun Ilhan
Michael Staehler
Show All
Source
Cite
Save
Citations (6)
18 F-FET PET uptake characteristics of long-term IDH-wildtype glioma survivors
2020
L. M. Mittlmeier
Marcus Unterrainer
Bogdana Suchorska
Peter Bartenstein
Jc Tonn
Nathalie L. Albert
Show All
Source
Cite
Save
Citations (0)
Advanced molecular imaging in histologically verified metanephric adenoma.
2020
Urology
L. M. Mittlmeier
Marcus Unterrainer
Andrei Todica
Dirk-André Clevert
Clemens C. Cyran
E. Schmoeckel
Severin Rodler
Peter Bartenstein
C.G. Stief
Harun Ilhan
Michael Staehler
Show All
Source
Cite
Save
Citations (0)
1